Login / Signup

Description of subgroup reporting in clinical trials of chronic diseases: a meta-epidemiological study.

Lili WeiElaine W ButterlyJesús Rodríguez PérezAvirup ChowdhuryRichard ShemiltPeter HanlonDavid McAllister
Published in: BMJ open (2024)
CRD42018048202.
Keyphrases
  • clinical trial
  • phase iii
  • adverse drug
  • phase ii
  • open label
  • double blind
  • study protocol
  • emergency department
  • randomized controlled trial